1.5 Abstract su Rivista

1.5 Abstract su Rivista: [1204] Home page tipologia

Sfoglia

Prodotti della tipologia (ordinati per Data di deposito in Decrescente ordine): 701 a 720 di 1.204

Regulation of the expression of Fc-epsilon-R in the human monocyte like cell line U937 by TPA and IgE.

1988 G., Rossi; S., Salzano; C., Pucillo; Pepe, Stefano; S., Formisano

Blast cells DNA content in childhood leukemias.

1987 Pepe, Stefano; A., Iolascon; P., Indolfi; M. T., Di Tullio; F., Bresciani; S., Cutillo

Up-regulation of EGF-receptor induced by alpha-interferon in human A431 cells.

1990 A., Budillon; P., Tagliaferri; C., Dilazzaro; M., Torrisi; G., Palmieri; G., Genua; M., Caraglia; Pepe, Stefano; R., Muraro; L., Frati; A. R., Bianco

Introducing an autophosphorylation site mutation in the RII-beta regulatory subunit of cAMP-dependent Protein-Kinase abolishes the RII-beta -mediated regulatory function.

1994 M., Nesterova; A., Budillon; Pepe, Stefano; A., Cereseto; Y. S., Cho Chung

Synergistic antitumor effect of novel mixed backbone oligonucleotides targeting protein kinase A in combination with cytotoxic drugs or biological agents.

1998 G., Tortora; R., Caputo; V., Damiano; Pepe, Stefano; A. R., Bianco; S., Agrawal; J., Mendelsohn; F., Ciardiello

Synerglstic antltumor effect by novel modified oligonucleotides targeting PKAI combined with cytotoxic drugs or monoclonal antibodies.

1998 G., Tortora; V., Damiano; R., Bianco; Pepe, Stefano; A. R., Bianco; S., Agrawal; J., Mendelsohn; F., Ciardiello

Oral antisense targeting protein kinase A type I causes antitumor and apoptotic effect in human cancer cells in vitro and in vivo and has cooperative activity in combination with antisense bcl-2.

1999 G., Tortora; R., Caputo; V., Damiano; R., Bianco; Pepe, Stefano; S., De Placido; A. R., Bianco; S., Agrawal; F., Ciardiello

Growth inhibition of tumor cells by epidermal growth factor receptor tyrosine kinase inhibitor ZD1839 is associated with upregulation of p27 and p21 cyclin-dependent kinase inhibitors.

1999 E., Di Gennaro; M., Barbarino; F., Bruzzese; S., De Lorenzo; Pepe, Stefano; F., Caponigro; A., Budillon

EGF-R tyrosyne kinase as new target in melanoma treatment; Synergistic effect of IFN alpha in combination with ZD1839 )Iressa) , an EGFR tyrosine kinase inhibitor.

2001 E., Di Gennaro; F., Bruzzese; A., Avallone; G., Pirozzi; Pepe, Stefano; G., Comella; F., Caponigro; A., Budillon

MEK-1 inhibitor PDO8059 potentiates apoptosis and growth inhibition induced by intereferon alpha (IFN alpha) in human epidermoid cancer cells.

2000 M., Caraglia; P., Tagliaferri; P., Tassone; G., Giuberti; M., Marra; Pepe, Stefano; A., Budillon; E., Di Gennaro; A. R., Bianco; A., Abbruzzese; S., Venuta

Growth arrest, apoptosis and potentiation of 5-fluorouracil and Raltitrexed cytotoxic effect induced by histone deacetylase inhibitor SAHA in colorectal cancer cells.

2002 A., Budillon; E., Di Gennaro; Pepe, Stefano; F., Bruzzese; G., Romano; I., Pelagianis; P., Mascagni; F., Leoni

A phase II study of biweekly oxaliplatin plus infusional 5-fluorouracil and folinic acid (FLFOX-4) as first-line treatment of advanced gastric cancer patients.

2004 F., De Vita; M., Orditura; E., Matano; R., Bianco; C., Carlomagno; S., Infusino; V., Damiano; E., Simeone; M. R., Diadema; E., Lieto; P., Castellano; Pepe, Stefano; S., De Placido; G., Galizia; F., Ciardiello; G., Catalano; A. R., Bianco

A phase I-II trial of gefitinib (IRESSA) and radiotherapy in patients with locally advanced inoperable squamous cell carcinoma of the head and neck (SCCHN)

2005 F., Caponigro; G., Franchin; V., Rav; G., Silvestro; B., Morrica; C., Romano; E., Minatel; Pepe, Stefano

The farnesyltransferase inhibitor R115777 (Zanestra) synergizes with ionizing radiation in inducing cell cycle perturbation and growth inhibition of human epidermoid head and neck cancer cells.

2006 Pepe, Stefano; Pacelli, R.; Chianese, M.; Budillon, A.; Abbruzzese, A.; Marra, M.; Sabbatino, F.; Laus, G.; Caraglia, M.

Potentiation of the antitumor acitivity of bortezomib, a proteasome inhibitor, by the combination with EGFR inhibitors in human cancer cell lines.

2006 T., Cascone; F., Morgillo; G., Laus; Pepe, Stefano; F., Ciardiello

Synergistic antitumor activity of the combination of the multi-targetes tyrosine kinase inhibitor sorafenib and of EGFR inhibitors in human colon and lung cancer cell lines.

2006 E., Martinell; T., Troiani; G., Laus; Pepe, Stefano; F., Ciardiello

Phase I-II study of xelox and bevacizumab plus erlotinib in sequential combination (XELO-TARAV) in first line colorectal cancer: Run in part.

2007 G., Tortora; C., Carlomagno; R., Bianco; G., Daniele; Pepe, Stefano; D., Leopardo; R., Marciano; M., De Laurentiis; F., Ciardiello; S., De Placido

Inhibition of poly(ADP-Ribose)plymerase synergizes with the DNA-topoisomerase-1-inhibitor, topoteca, and radiation in human glioblastoma cell lines.

2008 Sabbatino, F.; Pacelli, R.; Punzo, G.; Fusciello, C.; Vernieri, C.; Della Vittoria Scarpati, G.; Pepe, Stefano

Cell growth-inhibition and cell cycle perturbations induced by a new synthetic iminoquinone, 5H-pyridophenoxazin-5-one, in human breast carcinoma cell lines.

2007 Fusciello, C.; Bolognose, A.; La Vecchia, A.; Ubezio, P.; Sabbatino, F.; Pepe, Stefano

Predictive factors of response to neoadjuvant chemoradiotherapy in rectal cancer patirnts.

2008 C., Carlomagno; F., D'Armiento; A., Crispo; G., Della Vittoria Scarpati; M., D'Armiento; M., Marra; L., Cannella; A., De Stefano; M., Colantuoni; S., Alfieri; S., De Placido; Pepe, Stefano

Titolo	Data di pubblicazione	Autore(i)
Regulation of the expression of Fc-epsilon-R in the human monocyte like cell line U937 by TPA and IgE.	1-gen-1988	G., Rossi; S., Salzano; C., Pucillo; Pepe, Stefano; S., Formisano
Blast cells DNA content in childhood leukemias.	1-gen-1987	Pepe, Stefano; A., Iolascon; P., Indolfi; M. T., Di Tullio; F., Bresciani; S., Cutillo
Up-regulation of EGF-receptor induced by alpha-interferon in human A431 cells.	1-gen-1990	A., Budillon; P., Tagliaferri; C., Dilazzaro; M., Torrisi; G., Palmieri; G., Genua; M., Caraglia; Pepe, Stefano; R., Muraro; L., Frati; A. R., Bianco
Introducing an autophosphorylation site mutation in the RII-beta regulatory subunit of cAMP-dependent Protein-Kinase abolishes the RII-beta -mediated regulatory function.	1-gen-1994	M., Nesterova; A., Budillon; Pepe, Stefano; A., Cereseto; Y. S., Cho Chung
Synergistic antitumor effect of novel mixed backbone oligonucleotides targeting protein kinase A in combination with cytotoxic drugs or biological agents.	1-gen-1998	G., Tortora; R., Caputo; V., Damiano; Pepe, Stefano; A. R., Bianco; S., Agrawal; J., Mendelsohn; F., Ciardiello
Synerglstic antltumor effect by novel modified oligonucleotides targeting PKAI combined with cytotoxic drugs or monoclonal antibodies.	1-gen-1998	G., Tortora; V., Damiano; R., Bianco; Pepe, Stefano; A. R., Bianco; S., Agrawal; J., Mendelsohn; F., Ciardiello
Oral antisense targeting protein kinase A type I causes antitumor and apoptotic effect in human cancer cells in vitro and in vivo and has cooperative activity in combination with antisense bcl-2.	1-gen-1999	G., Tortora; R., Caputo; V., Damiano; R., Bianco; Pepe, Stefano; S., De Placido; A. R., Bianco; S., Agrawal; F., Ciardiello
Growth inhibition of tumor cells by epidermal growth factor receptor tyrosine kinase inhibitor ZD1839 is associated with upregulation of p27 and p21 cyclin-dependent kinase inhibitors.	1-gen-1999	E., Di Gennaro; M., Barbarino; F., Bruzzese; S., De Lorenzo; Pepe, Stefano; F., Caponigro; A., Budillon
EGF-R tyrosyne kinase as new target in melanoma treatment; Synergistic effect of IFN alpha in combination with ZD1839 )Iressa) , an EGFR tyrosine kinase inhibitor.	1-gen-2001	E., Di Gennaro; F., Bruzzese; A., Avallone; G., Pirozzi; Pepe, Stefano; G., Comella; F., Caponigro; A., Budillon
MEK-1 inhibitor PDO8059 potentiates apoptosis and growth inhibition induced by intereferon alpha (IFN alpha) in human epidermoid cancer cells.	1-gen-2000	M., Caraglia; P., Tagliaferri; P., Tassone; G., Giuberti; M., Marra; Pepe, Stefano; A., Budillon; E., Di Gennaro; A. R., Bianco; A., Abbruzzese; S., Venuta
Growth arrest, apoptosis and potentiation of 5-fluorouracil and Raltitrexed cytotoxic effect induced by histone deacetylase inhibitor SAHA in colorectal cancer cells.	1-gen-2002	A., Budillon; E., Di Gennaro; Pepe, Stefano; F., Bruzzese; G., Romano; I., Pelagianis; P., Mascagni; F., Leoni
A phase II study of biweekly oxaliplatin plus infusional 5-fluorouracil and folinic acid (FLFOX-4) as first-line treatment of advanced gastric cancer patients.	1-gen-2004	F., De Vita; M., Orditura; E., Matano; R., Bianco; C., Carlomagno; S., Infusino; V., Damiano; E., Simeone; M. R., Diadema; E., Lieto; P., Castellano; Pepe, Stefano; S., De Placido; G., Galizia; F., Ciardiello; G., Catalano; A. R., Bianco
A phase I-II trial of gefitinib (IRESSA) and radiotherapy in patients with locally advanced inoperable squamous cell carcinoma of the head and neck (SCCHN)	1-gen-2005	F., Caponigro; G., Franchin; V., Rav; G., Silvestro; B., Morrica; C., Romano; E., Minatel; Pepe, Stefano
The farnesyltransferase inhibitor R115777 (Zanestra) synergizes with ionizing radiation in inducing cell cycle perturbation and growth inhibition of human epidermoid head and neck cancer cells.	1-gen-2006	Pepe, Stefano; Pacelli, R.; Chianese, M.; Budillon, A.; Abbruzzese, A.; Marra, M.; Sabbatino, F.; Laus, G.; Caraglia, M.
Potentiation of the antitumor acitivity of bortezomib, a proteasome inhibitor, by the combination with EGFR inhibitors in human cancer cell lines.	1-gen-2006	T., Cascone; F., Morgillo; G., Laus; Pepe, Stefano; F., Ciardiello
Synergistic antitumor activity of the combination of the multi-targetes tyrosine kinase inhibitor sorafenib and of EGFR inhibitors in human colon and lung cancer cell lines.	1-gen-2006	E., Martinell; T., Troiani; G., Laus; Pepe, Stefano; F., Ciardiello
Phase I-II study of xelox and bevacizumab plus erlotinib in sequential combination (XELO-TARAV) in first line colorectal cancer: Run in part.	1-gen-2007	G., Tortora; C., Carlomagno; R., Bianco; G., Daniele; Pepe, Stefano; D., Leopardo; R., Marciano; M., De Laurentiis; F., Ciardiello; S., De Placido
Inhibition of poly(ADP-Ribose)plymerase synergizes with the DNA-topoisomerase-1-inhibitor, topoteca, and radiation in human glioblastoma cell lines.	1-gen-2008	Sabbatino, F.; Pacelli, R.; Punzo, G.; Fusciello, C.; Vernieri, C.; Della Vittoria Scarpati, G.; Pepe, Stefano
Cell growth-inhibition and cell cycle perturbations induced by a new synthetic iminoquinone, 5H-pyridophenoxazin-5-one, in human breast carcinoma cell lines.	1-gen-2007	Fusciello, C.; Bolognose, A.; La Vecchia, A.; Ubezio, P.; Sabbatino, F.; Pepe, Stefano
Predictive factors of response to neoadjuvant chemoradiotherapy in rectal cancer patirnts.	1-gen-2008	C., Carlomagno; F., D'Armiento; A., Crispo; G., Della Vittoria Scarpati; M., D'Armiento; M., Marra; L., Cannella; A., De Stefano; M., Colantuoni; S., Alfieri; S., De Placido; Pepe, Stefano

Prodotti della tipologia (ordinati per Data di deposito in Decrescente ordine): 701 a 720 di 1.204

Legenda icone

file ad accesso aperto
file disponibili sulla rete interna
file disponibili agli utenti autorizzati
file disponibili solo agli amministratori
file sotto embargo
nessun file disponibile

Scopri

Accesso al fulltext

no fulltext1203
open1

UniSa - IRIS Institutional Research Information System